Stock Splits
By The Online Investor Staff, updated Fri., May. 24, 8:00 AM
| This Slide: #4 of 25 |
Slide #4. Novavax, Inc. (NASDAQ:NVAX) — 1 for 20 Reverse Split
Announced:
5/8/2019
Stock Split:
1 for 20
Record Date:
5/10/2019
Pay Date:
5/10/2019
NVAX Optionable?:
Yes
Novavax is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. Using recombinant nanoparticle vaccine technology, Co. produces vaccine candidates to respond to disease threats. Co.'s product pipeline targets a variety of infectious diseases, with clinical vaccine candidates for respiratory syncytial virus and the Ebola virus, and preclinical programs for other infectious disease vaccine candidates. Co. is also developing immune stimulating saponin-based adjuvants through its subsidiary, Novavax AB.
NVAX SEC Filing Email Alerts Service
NVAX Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the NVAX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
  
|
Buy (2.86 out of 4) 30th percentile
(ranked lower than approx. 70% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
